TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07457229: Radiprodil in Participants With Hepatic Impairment

Sponsor: GRIN Therapeutics, Inc. · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 40 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$3,567,008

Rescue Site Savings

+$2,347,904

Unlock Full NCT07457229 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07457229 Rescue Dossier →